Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.12.27.521482Source: DataRank Database

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (19)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Kevin D. Nusser,Kristen L. Jones ORCID,Pushkar Shinde ORCID,Catherine Z. Beach ORCID,Clare Keddy ORCID

Live enrichment

PubMed:21097893

National Institutes of Health

Grant: 5R01CA233495-05

Functional impact, mechanistic role, and targetability of ROS1 aberrations in cancer

National Institutes of Health

Grant: 5F30CA247253-04

Resistance Mechanisms in ROS1-Fusion-Driven Malignancies

greenLicense: CC BY

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2022/12/27/2022.12.27.521482.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.12.27.521482

https://doi.org/10.1101/2022.12.27.521482

https://doi.org/10.15252/emmm.202217367

https://pubmed.ncbi.nlm.nih.gov/37587872

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Medicine (General)Lung Neoplasmscancer mutationsMutation, MissenseArticlesTyrosine Kinase InhibitorsQH426-470Protein-Tyrosine KinasesTKIR5-920Carcinoma, Non-Small-Cell LungProto-Oncogene ProteinsGeneticsHumansROS1Protein Kinase Inhibitors